aidot

[View Original Text]

Aidot, an artificial intelligence medical device company, emphasized

the excellence of Cerviray AI, a remote diagnosis AI system for cervical cancer, and the importance of early detection at the recently held Indonesian Congress of Obstetrics and 

Gynecology (BCCOG 2023).

BCCOG, which celebrated its 5th anniversary this year, invited a number of prominent speakers in the field of obstetrics and gynecology to present in-depth discussions on the latest 

trends and treatment methods and to share techniques.

At this academic conference, Ali Budi Harsono, an obstetrician and gynecologist at Hasan Sadikin Hospital in Indonesia, presented the importance of early detection of cervical 

cancer through Cerviray under the theme of ‘Cerviray-applied innovation for early detection of cervical cancer’.

In addition, PYRIDAM Pharma, Indonesia's local partner of AIDOT, drew a lot of attention from participants by directly demonstrating the product at the conference booth exhibition.

AIDOT announced that it received approval for Cerviray's 510K from the U.S. Food and Drug Administration (FDA) in December of last year, and is accelerating preparations for 

full-scale entry into the United States.

Korea Economy TV / Reporter Jae-joon Yang / 23rd. Feb. 2023